I'm hearing very positive news to come out by the AGM regarding FDA approval, and a few other things relating to proceeding superbug through to clinical trials and positive developments on the integrase drug. AGM is Nov 20.
Massive upside potential from here. FDA approval will see the stock between 80c to $1, then a licensing deal with big pharma for North America well through $1...and that's just the beginning. ATC looks the goods to be a blockbuster drug of US$800m - $1bn pa in sales. GSK have much to be concerned about as ATC approaches market with strong potential to reduce 3TC's annual sales in excess of US$1bn pa.
This management team are really starting to deliver. But if the market doesn't price AVX right a corporate will do it for them.
AVX Price at posting:
0.0¢ Sentiment: Buy Disclosure: Not Held
